RxDoctor Payments Data

Ashutosh Shukla, MD

Nephrology · Gainesville, FLNPI 1558585711

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,830 of the $1,899 with a category attached, or 96.4%. Amgen accounts for 98.8% of it on its own, with 1 other manufacturer making up the rest.

$1,899in general payments, 2019–2025

Across 3 payments — averaging $632.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • GSK$23
$184,346in research payments, 2019–2025

Across 4 payments — averaging $46,086 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$184K

What the payments were for

  • Consulting fees$1,83096%
  • Food & beverage$694%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen2$1,876
GSK1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,899 in reported general payments places this provider in the 55th percentile of 756 nephrology providers in Florida.

See all nephrology providers in Florida →

Medicare billing

Part B allowed, 2024
$45,710
Medicare patients
100
Services billed
292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sevelamer Carbonate11$3,098
Furosemide30$337
Losartan Potassium24$166
Carvedilol12$70
Lisinopril12$62
Amlodipine Besylate13$41

Paid to pharmacies, not to this prescriber.

Other nephrology in Gainesville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →